Foghorn Therapeutics Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -4.34 | -100% |
| P/S |
|
8.16 | 33.76 | -75.83% |
|
|
| P/BV |
|
-3.61 | 4.82 | -174.9% |
|
|
| P/FCF |
|
0 | 60.98 | -100% |
|
|
| Ev/Ebitda |
|
-2.45 | -22.12 | -88.91% |
|
|
| Ev/S |
|
7.13 | 22.56 | -68.41% |
|
|
| Ev/FCF |
|
-2.04 | 68.75 | -102.97% |
|
|
| E/P |
|
0 | 0.0178 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-290.57 | 4.83 | -6115.54% | -5869.37 | -95.05% |
| ROE |
|
127.51 | 9.61 | 1227.39% |
|
|
| ROA |
|
-34.42 | 0.3359 | -10348.36% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
-288.17 | -25.17 | 1044.89% |
|
|
| ROCE |
|
139.79 | 15.33 | 811.82% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.4542 | -3.67 | -87.61% | -0.4664 | -2.63% |
| Nеt Debt/Ebitda |
|
0.3553 | -3.44 | -110.33% |
|
|
| Debt/Ratio |
|
0.1576 | 0.1972 | -20.04% |
|
|
| Debt/Equity |
|
0 | 1.65 | -100% |
|
|
| Debt/Net Income |
|
-0.4579 | 10.31 | -104.44% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5496 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.1053 | -100% | ||
| DSI |
|
0 | 0.2174 | -100% |
|
|
| Average dividend growth |
|
0 | 0.0654 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4928 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5496 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
7843.02 | -56.89 | -13886.29% | ||
| Growth impulse Ebitda in 5 years |
|
98.89 | -64.81 | -252.58% | ||
| Growth impulse Net Income in 5 years |
|
90.38 | -58.33 | -254.95% | ||
| Growth impulse FCF in 5 years |
|
152.28 | -47 | -424% | ||
| Growth impulse EPS in 5 years |
|
0.2094 | -32.41 | -100.65% |
IP Score
5/10
